Delivery Order SPE2DB20D7066-SPE2DB25FC3NX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,215.11 to AmerisourceBergen Drug Corp for Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packages of six on August 11, 2025. This firm fixed price delivery order, which is expected to be completed by August 12, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $18,142.31 delivery order to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 2.5 mg tablets in unit dose packages of 6, with a completion date of August 1, 2025. This competitively awarded, firm fixed-price contract reflects no set-aside designation and represents a routine pharmaceutical procurement supporting federal healthcare operations. The contract is executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- This delivery order, awarded August 8, 2025, by the Defense Logistics Agency's Medical Supply Chain, procures Zolmitriptan 2.5 mg oral disintegrating tablets (unit dose, 6-count packages) from AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The firm fixed price delivery order, valued at $1,334.50, is scheduled for completion by August 11, 2025, with performance occurring at the vendor's Conshohocken facility. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.66 to AmerisourceBergen Drug Corp for the supply of Zolmitriptan 5 mg tablets (3-packs). The contract was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and carries a firm fixed price structure with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $38,500 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of Zolmitriptan 2.5 mg tablets. Under this order, Amerisourcebergen will deliver 6 packages of the migraine medication to a facility in Conshohocken, Pennsylvania by June 28, 2023 in support of the Defense Logistics Agency's medical supply needs. As a top 10 prime contractor on DLA's Pharmaceutical Prime Vendor contract, Amerisourcebergen routinely provides...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,425.20 contract is for the supply of zolmitriptan 2.5 mg orally disintegrating tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
- The Defense Logistics Agency Troop Support Medical awarded a $171,720 delivery order to Amerisourcebergen Drug Corporation for the supply of Zolmitriptan 5mg orally disintegrating tablets. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical product to a facility in Conshohocken, Pennsylvania by September 12, 2023. Amerisourcebergen will serve as the prime contractor on the fixed-price order, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,565,192,588 units of Zolmitriptan 5 mg tablets. The order, valued at $2,705.99, has a firm fixed-price contract type and an ultimate completion date of July 19, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, has been awarded this contract as well as several Indefinite Delivery Contracts (IDCs) by various federal agencies,...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,621.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,407,890 zolmitriptan 5 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award, valued at $1,779.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zolmitriptan 5 mg Orally Disintegrating Tablets, a prescription medication used to treat migraines. This is a firm-fixed-price delivery order contract with a completion date of March 31, 2023. The contract was not designated with a set-aside requirement,...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC3NXDelivery Order
The Defense Logistics Agency awarded a $1,281.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Zolmitriptan 2.5 mg orally disintegrating tablets in unit dose packaging (6-count). The contract is non-set-aside and competitively awarded, with a completion date of June 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is the prime contractor on this delivery order, which falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, likely for military or veteran healthcare systems. Zolmitriptan is a migraine treatment medication commonly stocked in military medical supply chains. The order demonstrates AmerisourceBergen Drug Corp's extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency across multiple therapeutic domains, with the company serving as a critical vendor for federal medical procurement through both small-value transactions and substantial orders under its comprehensive global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/2/25 |